These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 17601495

  • 1. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.
    Marder SR, Kramer M, Ford L, Eerdekens E, Lim P, Eerdekens M, Lowy A.
    Biol Psychiatry; 2007 Dec 15; 62(12):1363-70. PubMed ID: 17601495
    [Abstract] [Full Text] [Related]

  • 2. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL, Burns T, Morosini P, Gagnon DD, Rothman M, Adriaenssen I.
    Clin Ther; 2010 Feb 15; 32(2):275-92. PubMed ID: 20206786
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.
    Tzimos A, Samokhvalov V, Kramer M, Ford L, Gassmann-Mayer C, Lim P, Eerdekens M.
    Am J Geriatr Psychiatry; 2008 Jan 15; 16(1):31-43. PubMed ID: 18165460
    [Abstract] [Full Text] [Related]

  • 4. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA, Bettinger TL, Argo TR.
    Clin Ther; 2008 Feb 15; 30(2):231-48. PubMed ID: 18343262
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.
    Davidson M, Emsley R, Kramer M, Ford L, Pan G, Lim P, Eerdekens M.
    Schizophr Res; 2007 Jul 15; 93(1-3):117-30. PubMed ID: 17466492
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kramer M, Simpson G, Maciulis V, Kushner S, Vijapurkar U, Lim P, Eerdekens M.
    J Clin Psychopharmacol; 2007 Feb 15; 27(1):6-14. PubMed ID: 17224706
    [Abstract] [Full Text] [Related]

  • 9. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial.
    Kane J, Canas F, Kramer M, Ford L, Gassmann-Mayer C, Lim P, Eerdekens M.
    Schizophr Res; 2007 Feb 15; 90(1-3):147-61. PubMed ID: 17092691
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
    Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM.
    Int Clin Psychopharmacol; 2007 Sep 15; 22(5):299-308. PubMed ID: 17690599
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents.
    Singh J, Robb A, Vijapurkar U, Nuamah I, Hough D.
    Biol Psychiatry; 2011 Dec 15; 70(12):1179-87. PubMed ID: 21831359
    [Abstract] [Full Text] [Related]

  • 12. Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.
    Canuso CM, Youssef EA, Bossie CA, Turkoz I, Schreiner A, Simpson GM.
    Int Clin Psychopharmacol; 2008 Jul 15; 23(4):209-15. PubMed ID: 18545059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers.
    Canuso CM, Schooler N, Carothers J, Turkoz I, Kosik-Gonzalez C, Bossie CA, Walling D, Lindenmayer JP.
    J Clin Psychopharmacol; 2010 Oct 15; 30(5):487-95. PubMed ID: 20814330
    [Abstract] [Full Text] [Related]

  • 16. Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study.
    Schmauss M, Jukić V, Siracusano A, Bidzan L, Badescu GM, Maciulis V, Lahaye M, Hoeben D, Tessier C, Schreiner A.
    Curr Med Res Opin; 2012 Aug 15; 28(8):1395-404. PubMed ID: 22746355
    [Abstract] [Full Text] [Related]

  • 17. Paliperidone extended release: a review of its use in the management of schizophrenia.
    Chwieduk CM, Keating GM.
    Drugs; 2010 Jul 09; 70(10):1295-317. PubMed ID: 20568835
    [Abstract] [Full Text] [Related]

  • 18. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.
    Berwaerts J, Cleton A, Rossenu S, Talluri K, Remmerie B, Janssens L, Boom S, Kramer M, Eerdekens M.
    J Psychopharmacol; 2010 Jul 09; 24(7):1011-8. PubMed ID: 19825908
    [Abstract] [Full Text] [Related]

  • 19. Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.
    Canuso CM, Grinspan A, Kalali A, Damaraju CV, Merriman U, Alphs L, Awad AG.
    Int Clin Psychopharmacol; 2010 May 09; 25(3):155-64. PubMed ID: 20216424
    [Abstract] [Full Text] [Related]

  • 20. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ, Kalali AH, Weiden PJ, Hamilton J, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr 09; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.